2018 DRAFT AGENDA

WEDNESDAY, NOVEMBER 14, 2018
(All Speakers Confirmed Unless Noted Otherwise)

HHS KEYNOTE ADDRESS
HHS Deputy Secretary Eric Hargan

THE DRUG PRICING BLUEPRINT
Deputy Assistant Secretary (Health Policy) for Planning and Evaluation John O'Brien
Senior Advisor to the Secretary for Drug Pricing Reform Daniel Best

VALUE-BASED MODELS IN THE REAL WORLD
(Coming Soon)

CENTER DIRECTORS PANEL
CDER Director Janet Woodcock
CBER Director Peter Marks
OCE Director Richard Pazdur

OMB OUTLOOK FOR 2019
OMB Associate Director, Health Programs Joe Grogan

CMS KEYNOTE
CMS Administrator Seema Verma (Invited)

ELECTION IMPACT ON 2019
(Coming Soon)

BIOPHARMA CEOs PANEL
Loxo Oncology CEO Joshua Bilenker
(Coming Soon)

HOW TO SAVE ANTIBIOTICS
Office of Antimicrobial Products Director Ed Cox (Invited)

THE NEW OND
FDA Office of New Drugs Deputy Director Peter Stein

FDA'S RISING STARS PANEL
CDER Deputy Director for Clinical Science Bob Temple
Office of New Drugs Supervisory Medical Officer, Immediate Office, James Smith